ANHUI POLY PHARM CO LTD
ANHUI POLY PHARM CO LTD (China) holds 16 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 14 active ingredients, holds 6 active Type IV (excipient) Drug Master Files and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “ANHUI POLY PHARM CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/anhui-poly-pharm-co-ltd
Overview
ANHUI POLY PHARM CO LTD is an active pharmaceutical ingredient (API) supplier with 15 active FDA Type II Drug Master Files, covering ALLOPURINOL USP; APREMILAST; CRISABOROLE; CYCLOPHOSPHAMIDE USP; GADOBUTROL USP; GADOTERATE MEGLUMINE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which ANHUI POLY PHARM CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
ANHUI POLY PHARM CO LTD holds 16 active (17 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- BOROFALAN (10B)Active2026-05-14
- IODIDE (INTERMEDIATE)Active2025-07-31
- HYDROLYSATE (INTERMEDIATE)Active2025-07-31
- IOVERSOL USPActive2025-07-30
- SEMAGLUTIDEActive2025-02-28
- ALLOPURINOL USPActive2024-07-29
- SODIUM NITROPRUSSIDE USPActive2024-05-31
- GADOBUTROL USPActive2023-11-30
- CRISABOROLEActive2023-11-30
- TECOVIRIMAT MONOHYDRATEActive2023-09-20
- VORICONAZOLE USPActive2023-09-01
- APREMILASTActive2023-08-15
- GADOTERIDOL USPActive2023-02-09
- CYCLOPHOSPHAMIDE USPActive2022-07-14
- GADOTERATE MEGLUMINEActive2022-05-31
- MAGNESIUM HYDROXIDE USPActive2021-12-16
- MEMANTINE HYDROCHLORIDE USPInactive2022-11-29
Excipient Drug Master Files
ANHUI POLY PHARM CO LTD holds 6 active (6 total) FDA Type IV Drug Master Files. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- SM-102 (HEPTADECAN-9-YL 8-((2-HYDROXYETHYL)(6-OXO-6-(UNDECYLOXY)HEXYL)AMINO)OCTANOATE)Active2024-11-29
- SALCAPROZATE SODIUMActive2024-03-14
- CALCOBUTROL SODIUMActive2023-12-29
- CALTERIDOL CALCIUMActive2023-02-28
- BETADEX SULFOBUTYL ETHER SODIUM USPActive2022-12-28
- TETRAXETAN USPActive2022-05-31
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to ANHUI POLY PHARM CO LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to ANHUI POLY PHARM CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this ANHUI POLY PHARM CO LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.